首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Comparative evaluation of flow-cytometric immunophenotyping and immunocytochemistry in the categorization of malignant small round cell tumors in fine-needle aspiration cytologic specimens.
【24h】

Comparative evaluation of flow-cytometric immunophenotyping and immunocytochemistry in the categorization of malignant small round cell tumors in fine-needle aspiration cytologic specimens.

机译:流式细胞仪免疫表型和免疫细胞化学在细针穿刺细胞学标本中恶性小圆形细胞肿瘤分类中的比较评价。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The precise diagnosis of malignant small round cell tumors (MSRCTs) in fine-needle aspiration (FNA) cytology is a challenge that requires ancillary investigations. In this study, the authors evaluated the applicability of flow-cytometric immunophenotyping (FCI) and compared it with immunocytochemistry (ICC) for the accurate categorization of MSRCTs. METHODS: In total, 37 consecutive MSRCTs that had been diagnosed with FNA cytology were analyzed by ICC and FCI using a panel of antibodies against desmin, vimentin, CD99/major histocompatibility class I-related antigen 2, neuron-specific enolase, and pancytokeratin. The final diagnoses included Ewing sarcoma (n = 17), rhabdomyosarcoma (n = 6; 4 embryonal and 2 alveolar subtypes), neuroblastoma (n = 10), desmoplastic small round cell tumor (n = 2), and retinoblastoma (n = 2). RESULTS: Accurate categorization was possible in 67.5% of cases by ICC and in 64.8% of cases by FCI. Concordant immunophenotyping results with either technique were obtained in 21 cases (59.4%). Low cellularity of the sample and negativity for all markers tested were some limitations to both techniques when applied on fine-needle aspirates. However, using a combination of both techniques, 86.4% (32 of 37 cases) MSRCTs were typed accurately. CONCLUSIONS: FCI is applicable on FNA material and complements ICC in accurate the typing of MSRCTs. This is particularly useful in advanced-stage disease, when neoadjuvant chemotherapy may be instituted promptly.
机译:背景:细针穿刺(FNA)细胞学中的恶性小圆形细胞瘤(MSRCTs)的精确诊断是一项需要辅助研究的挑战。在这项研究中,作者评估了流式细胞免疫表型(FCI)的适用性,并将其与免疫细胞化学(ICC)进行了比较,以对MSRCT进行准确分类。方法:使用抗结蛋白,波形蛋白,CD99 /主要组织相容性I类相关抗原2,神经元特异性烯醇化酶和全细胞角蛋白的抗体,通过ICC和FCI对总共诊断为FNA细胞学的37例连续MSRCT进行了分析。最终诊断包括尤因肉瘤(n = 17),横纹肌肉瘤(n = 6; 4种胚胎和2种肺泡亚型),神经母细胞瘤(n = 10),增生性小圆形细胞瘤(n = 2)和视网膜母细胞瘤(n = 2) )。结果:ICC的准确分类率为67.5%,FCI的准确分类为64.8%。两种方法均获得了一致的免疫表型鉴定结果(21例,占59.4%)。当应用到细针抽吸物中时,样品的低细胞流动性和所有测试标记物的阴性均是两种技术的局限性。但是,结合使用这两种技术,可以准确键入86.4%(37例中的32例)MSRCT。结论:FCI适用于FNA材料并补充了ICC,可准确地进行MSRCT的分型。当可以迅速开始新辅助化疗时,这在晚期疾病中特别有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号